Observational studyThe British journal of dermatology2021

Biologic drug survival rates in the era of anti-interleukin-17 antibodies: a time-period-adjusted registry analysis.

T Graier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.